Aminocaproic Acid
Call to order(859) 281-9511General Drug Information and Indications
Antifibrinolytic for hemorrhage associated with hyperfibrinolysis in horses and dogs; perioperative hemostasis; investigational use in canine degenerative myelopathy.
Antifibrinolytic agent (aminocaproic acid). Mechanism: competitively inhibits plasminogen activation, preventing plasmin formation and fibrin clot dissolution. Inhibits fibrinolysis without affecting coagulation cascade. Also investigated for neuroprotective effects via anti-apoptotic mechanisms.
Key information
Aminocaproic acid injectable — see aminocaproic acid entry. Refrigerate. IV infusion preferred. Monitor for thrombotic events.
How to Give this Medication
IV: dilute in 0.9% NaCl or D5W; administer loading dose over 15–30 min, then maintenance CRI. Oral: Administer orally. May be given with food to improve compliance and reduce GI upset. Administer with food to reduce GI adverse effects. Store at room temperature; protect from light.
If a dose is missed
This medication is administered by a veterinarian or veterinary staff in a clinical setting. Missed doses are managed by your veterinary team — contact your veterinarian to reschedule.
Side Effects
GI: nausea, vomiting, diarrhea, abdominal cramping. Cardiovascular: hypotension (rapid IV). CNS: dizziness, agitation. Thrombotic risk (excessive inhibition of fibrinolysis) — use caution in hypercoagulable states. Myopathy with prolonged high-dose use.
Precautions
For animals
Avoid in pregnant animals. — antifibrinolytics may affect placental blood flow. Avoid in disseminated intravascular coagulation (DIC) or thromboembolic disorders. Use caution in cardiac and renal disease. Monitor for thrombotic complications.
For people handling this medication
Wash hands thoroughly with soap and water after handling. Avoid contact with eyes; if contact occurs, flush with water for 15 minutes and seek medical attention. Keep out of reach of children. If accidental ingestion occurs, contact Poison Control (1-800-222-1222). Keep out of reach of children. Pregnant women and women of childbearing age should avoid contact.
Overdose
Contact your veterinarian immediately. Supportive care required for overdose.
Aminocaproic Acid dosage forms
| Product | Strength | Form | Size | Type |
|---|---|---|---|---|
| AMINOCAPR AC INJ 250MG/ML | 250MG/ML | Injectable | — | Commercial |
| AMINOCAPR AC INJ 250MG/ML | 250MG/ML | Injectable | — | Commercial |
| AMINOCAPROIC ACID INJECTION 250MG/ML | 250 MG/ML | Injectable | 1 | Commercial |
Sources
This information is provided for educational purposes and is not a substitute for advice from your veterinarian. Source: Merck Veterinary Manual (merckvetmanual.com); Plumb's Veterinary Drug Handbook (Plumb, D.C., app.plumbs.com)